Hot Topics in Microbiology. Fall 2010 Course: Biology 225 I nstructor: Dr. Janie Sigmon. Question #1:. There has been publicity about a “superbug” that has made its way from India/Pakistan to the U.S. What is this new superbug?
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Course: Biology 225
Instructor: Dr. Janie Sigmon
There isn’t just one species of bacteria. The enteric bacteria are developing this resistance.
The antibiotic resistance developed when a new gene, NDM-1 (New Delhi metallo-b-lactamase), was passed to these different species of bacteria by way of a plasmid (extra DNA).
Humans promote the evolution of antibiotic-resistance in bacteria by exposing the bacteria unnecessarily to the antibiotics. There are many ways that this occurs. Elective surgery “vacations” are helping to promote the spread of this type of resistance.
Detection of Enterobacteriaceae Isolates Carrying Metallo-Beta-Lactamase — United States, 2010
During January–June 2010, three Enterobacteriaceae isolates carrying a newly described resistance mechanism, the New Delhi metallo-beta-lactamase (NDM-1) (1), were identified from three U.S. states at the CDC antimicrobial susceptibility laboratory. This is the first report of NDM-1 in the United States, and the first report of metallo-beta-lactamase carriage among Enterobacteriaceae in the United States. These isolates, which include an Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae, carry blaNDM-1, which confers resistance to all beta-lactam agents except aztreonam (a monobactam antimicrobial) (1); all three isolates were aztreonam resistant, presumably by a different mechanism. In the United Kingdom, where these organisms are increasingly common, carriage of Enterobacteriaceae containing blaNDM-1 has been closely linked to receipt of medical care in India and Pakistan (2). All three U.S. isolates were from patients who received recent medical care in India.
Carbapenem resistance and carbapenemase production conferred by blaNDM-1 is detected reliably with phenotypic testing methods currently recommended by the Clinical and Laboratory Standards Institute (3), including disk diffusion testing and the modified Hodge test (4). Carbapenem resistance in all three of these isolates was detected in the course of routine testing. Current CDC infection control guidance for carbapenem-resistant Enterobacteriaceae also is appropriate for NDM-1–producing isolates (5). This includes recognizing carbapenem-resistant Enterobacteriaceae when cultured from clinical specimens, placing patients colonized or infected with these isolates in contact precautions, and in some circumstances, conducting point prevalence surveys or active-surveillance testing among other high-risk patients. Laboratory identification of the carbapenem- resistance mechanism is not necessary to guide treatment or infection control practices but should instead be used for surveillance and epidemiologic purposes.
Clinicians should be aware of the possibility of NDM-1–producing Enterobacteriaceae in patients who have received medical care in India and Pakistan, and should specifically inquire about this risk factor when carbapenem-resistant Enterobacteriaceae are identified. CDC asks that carbapenem-resistant isolates from patients who have received medical care within 6 months in India or Pakistan be forwarded through state public health laboratories to CDC for further characterization. Infection control interventions aimed at preventing transmission, as outlined in current guidance (5), should be implemented when NDM-1–producing isolates are identified, even in areas where other carbapenem-resistance mechanisms are common among Enterobacteriaceae. Additional information is available by contacting Brandi Limbago or Alex Kallen at email@example.com.
The Lancet journal published an article in 1998 by Wakefield et al. that came to the conclusion that autism was caused by exposure to thimerosal in the MMR vaccine.
After this work was published many studies have been done to show that this is true. The consensus in the scientific community is that there is no evidence to support this idea. Wakefield’s article was retracted from The Lancet and he has been disbarred from medicine in the U.K.
Vaccines are very safe. They protect us from diseases that kill or disable us. There can be side effects from the vaccines, however, including death. The incidence of serious side effects is much lower than the effects of the disease. It is estimated that the mortality rate for vaccines is on the order of 1 in 1 million vaccinations (or lower) – in other words, very rare.
People should be vaccinated against diseases in order to prevent illness and/or death.
C. diff = Clostridium difficile
People develop C. difficile infections following an antibiotic regimen.
C. difficile infections are treated with probiotics and antibiotics, such as metronidazole or vancomycin
The ground-breaking therapy is a fecal transplant where feces was taken from a father and introduced into his 2 year old daughter’s large intestine. http://www.infectiousdiseasenews.com/article/65702.aspx
Salmonella bacteria have been found in dry pet foods.
Children, the elderly, and anyone who is immunocompromised is at risk for severe salmonellosis.
Salmonellosis is a gastrointestinal disease with diarrhea, cramps, and fever.
The pet foods were recalled and the production plant was eventually permanently closed.http://www.infectiousdiseasenews.com/article/67398.aspx
Most people have been vaccinated against pertussis (whooping cough) or have been exposed to it.
It is becoming a problem around the U.S. because more people are opting not to have their children immunized or are spacing out immunizations.
This is the sound of whooping cough: